Among these was circARID1A, a circRNA derived from the ARID1A tumor suppressor gene (cirbase.org identifier40 hsa_circ_0008494), which was expressed more strongly in high-risk neuroblastoma samples that lacked MYCN amplifications (p < 1e−3; Supplementary Fig. 7). This evidence concerns the gene MYCN and neuroblastoma.